Advertisement

Topics

Oncimmune LLC Company Profile

23:44 EST 18th November 2017 | BioPortfolio

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer in high-risk asymptomatic patient populations. The key advantage of the test is its ability to detect cancer earlier, and with higher specificity, than spiral-CT which is the standard diagnostic imaging test used for these patients today. EarlyCDT-Lung is priced below a CT scan and as a simple blood test, eliminates radiation exposure from imaging screening techniques. High-risk individuals such as long-term smokers and ex-smokers between the ages of 40 and 75 and individuals with other risk factors such as environmental exposures and extensive exposure to secondary smoke are candidates for the test. Further research to investigate the most beneficial clinical use of the test (i.e., as a first test leading to further testing for those positive, or as a test providing further information to those who already have a CT identified nodule) is currently being finalized. EarlyCDT-Lung is CLIA (Clinical Laboratory Improvement Act) regulated. Other tests for breast, ovarian, esophagogastric, colon and liver cancers are planned. For more information about Oncimmune's EarlyCDT-Lung, visit: http://www.oncimmune.com .


News Articles [3 Associated News Articles listed on BioPortfolio]

Oncimmune LLC CMO Producing First Batch Of Tretinoin For Acute Promyelocytic Leukemia

  Life Sciences Jobs   ...

Oncimmune Ltd ONC Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryOncimmune Ltd Oncimmune is a biotechnology company that discovers and commercializes technologies for the early detection of cancer. The company develops EarlyCDT, a platform technology for det...

New funding to support cutting-edge technology announced by the Chancellor

The package includes:£100 million of funding to extend and enhance the Biomedical Catalyst, supporting innovative UK life science companies to translate cutting-edge medical technologies into co...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Oncimmune (USA) LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of...

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of...

More Information about "Oncimmune LLC" on BioPortfolio

We have published hundreds of Oncimmune LLC news stories on BioPortfolio along with dozens of Oncimmune LLC Clinical Trials and PubMed Articles about Oncimmune LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oncimmune LLC Companies in our database. You can also find out about relevant Oncimmune LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record